Exelixis
EXEL
#1765
Rank
โ‚น1.021 T
Marketcap
โ‚น3,795
Share price
0.96%
Change (1 day)
28.82%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company